By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Ab&B Bio Tech Co Ltd. (2627.HK)

HKSE Currency in HKD
$49.12
+$0.46
+0.95%
Last Update: 3 Sept 2025, 08:08
$19.33B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$33.00 - $59.60
52 Week Range

2627.HK Stock Price Chart

Explore Ab&B Bio Tech Co Ltd. interactive price chart. Choose custom timeframes to analyze 2627.HK price movements and trends.

2627.HK Company Profile

Discover essential business fundamentals and corporate details for Ab&B Bio Tech Co Ltd. (2627.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

11 Aug 2025

Employees

CEO

Youcai An

Description

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases. The company offers various vaccines, such as human rabies vaccine, pneumococcal vaccine, zoster vaccine, respiratory syncytial virus vaccine, mpox vaccine, varicella vaccine, and tetanus vaccine. The company was founded in 2015 and is based in Taizhou, China.

2627.HK Financial Timeline

Browse a chronological timeline of Ab&B Bio Tech Co Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

2627.HK Stock Performance

Access detailed 2627.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run